Status and phase
Conditions
Treatments
About
This is an open-label, single-arm study to assess the safety, tolerability and pharmacokinetics of Endostar subcutaneous injection in Chinese advanced NSCLC patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
8 participants in 1 patient group
Loading...
Central trial contact
Yanhong Zhu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal